NEUROENDOCRINE TUMOR LU-177-DOTATATE THERAPY
Tracking # 20-1053094
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
LU 177 DOTATATE THERAPY IS A TREATMENT MODALITY USED TO MANAGE AND TREAT NEUROENDOCRINE TUMOR PATIENTS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR LU 177 DOTATATE THERAPY AS A VALUABLE AGENT IN THE MANAGEMENT OF NEUROENDOCRINE OR CARCINOID TUMORS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL, MULTIDISCIPLINARY TEAMS INVOLVED IN MANAGING PATIENTS WITH ADVANCED NEUROENDOCRINE TUMORS.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I